GCP
CALC icon

GSA Capital Partners’s CalciMedica CALC Stock Holding History

GSA Capital Partners’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Buy
+23,777
New +$48.3K ﹤0.01% 1650
2022
Q1 		– Sell
-6,157
Closed -$158K – 1435
2021
Q4 		$158K Buy
+6,157
New +$239K 0.02% 1264

Other funds holding CALC

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GSA Capital Partners's CALC Position: Q1 2026 in Review

GSA Capital Partners opened a new position in CalciMedica (CALC) in Q1 2026: 23,777 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #1650 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in CALC as recently as Q4 2021.

GSA Capital Partners first reported a position in CALC in Q4 2021 and has held it in 2 quarters since. The position peaked at $158K in Q4 2021. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • GSA Capital Partners held 23,777 shares of CalciMedica worth $13K as of Q1 2026.
  • CalciMedica was a new GSA Capital Partners position in Q1 2026.
  • CalciMedica made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1650 holding.
  • GSA Capital Partners first reported a position in CalciMedica in Q4 2021 and has held it in 2 quarters since.
  • GSA Capital Partners's CalciMedica position peaked at $158K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.